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Abstract 10 
 11 
In livestock farming, sulfonamides (SAs) are used prophylactically and simultaneously 12 
in large numbers of animals. Therefore, traces of these compounds, alone or in 13 
combination, have been repeatedly detected in the environment. Synergistic interactions 14 
among chemicals in such mixtures represent an area of concern for the regulatory 15 
authorities. In this study, the acute toxic effects of binary and ternary mixtures of SAs 16 
were evaluated in Daphnia magna, in order to verify whether, based on their individual 17 
toxicity, they jointly exert a larger effect than would be predicted by individual actions 18 
alone. First, following the Concentration Addition (CA) principle, some preliminary 19 
observations were made by testing a number of drug combinations with an expected 20 
50% effect. Then, mixtures more recognised for their synergistic effect (four binary and 21 
two ternary) were assayed in a range of reducing concentrations. The data acquired were 22 
processed using CompuSyn software, which integrates the different shape of the curves 23 
obtained in calculating the Combination Index (CI) for the evaluation of synergistic 24 
effects.  For binary mixtures, synergy was also evaluated using the curvilinear 25 
isobologram method for heterodynamic drugs. Results indicate that most of the selected 26 
mixtures exhibit a synergistic effect using the CI methodology. For binary mixtures, 27 
these findings were also confirmed by isobologram analysis. Detected synergies indicate 28 
that the CA is not always precautionary as a reference model for the evaluation of the 29 
aquatic toxicity of SAs mixtures.  30 
 31 
 32 
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 34 
Introduction 35 
 36 
In livestock farming, antibacterial drugs are used not only for therapeutic treatment of 37 
infected animals, but also for the so-called ‘mass treatments’ involving, simultaneously, 38 
a large number of animals. The following are carried out: growth promoting treatments, 39 
characterized by small doses of antibacterial added daily to the food during much of the 40 
production cycle and aimed at increasing the productivity of the animals; prophylactic 41 
treatments, routinely scheduled at critical times of the breeding cycle (weaning, change 42 
of housing, transport, etc.); and metaphylactic treatments, implemented promptly at the 43 
onset of disease in one or more subject of the group and aimed at treating infection in 44 
those already sick and prevent it in the still healthy ones. In the EU, despite the ban of 45 
the use of antibiotics as growth promoters, there seems to be no significant decrease in 46 
the consumption of antibiotics in the veterinary sector, as they continue to be used 47 
systematically for "prophylactic" purposes, due to unsustainable agricultural practices 48 
(Bond and Jewel, 2014). 49 
Sulfonamides (SAs) are the oldest antibacterial agents and remain among the most 50 
widely used active pharmaceutical ingredients in veterinary medicine (EMA, 2015), 51 
mainly because of low cost and relative efficacy in some common bacterial and 52 
protozoan diseases.  53 
Many of the available Veterinary Medicinal Products (VMPs) containing SAs are 54 
marketed as a premix, to be added to feed, or as an oral solution to be added to water. 55 
Using these formulations, animals may be treated simultaneously for preventive 56 
purposes and this can result in a substantial environmental load of the drugs. SAs are 57 
subject to weak metabolism in the body of livestock and thus are eliminated mainly as 58 
such, or in the form of active metabolites in the excreta (Białk-Bielińska et al., 2013). 59 
As manure and slurry from farms are usually employed for the fertilization of 60 
agricultural land, a contamination of soil with SAs residues is clearly expected. During 61 
rainy days these residues can, partially at least, be transferred from soil to surface water 62 
by runoff (Boxall et al., 2002). Furthermore, SAs may also be directly released to 63 
watercourses as their use is extended to aquaculture in various countries. It is a matter 64 
of fact that residues of SAs have been repeatedly detected in the aquatic environment 65 
(Boxall et al., 2005; Perret et al., 2006; Xu et al., 2007; García-Galán et al., 2009; Santos 66 
et al., 2010; Guedes-Alonso et al., 2013; Giang et al., 2015). 67 
For many years, the small crustacean Daphnia magna has been recognised as a keystone 68 
species in the food webs of many continental water bodies, and has served as an 69 
important model for ecotoxicological research (Seda and Petrusek, 2011). Impacts on 70 
daphnid populations may reverberate across the entire aquatic ecosystem as they are 71 
principal grazers of algae and primary forage for fish in lentic in-land ecosystems 72 
(Colbourne et al., 2011). The acute toxicity of SAs to D. magna is usually low (EC50s 73 
>100 mg L-1) with the notable exception of Sulfaguanidine (EC50 6.2 mg L-1) (Dalla 74 
Bona et al., 2014). However, as SAs occur in natural environment not just as a single 75 
entity, but usually together with other compounds of the same family or the same type 76 
(Managaki et al., 2007; Baran et al., 2011; García-Galán et al., 2011), it is of interest to 77 
evaluate the toxicity of their mixtures. 78 
Here we adopted the concept of Concentration Addition (CA) to express the contribution 79 
of each chemical to the final mixture toxicity (Loewe and Muischnek, 1926). The 80 
concept is based on the assumption that all chemicals in a mixture act on the same 81 
biological target site and therefore could be viewed as being dilutions of each other, each 82 
having a different chemical potency (Cedergreen, 2014). Each chemical contribution to 83 
the overall toxicity of a mixture can be expressed as the quotient of its dose in the 84 
mixture and the dose of the same chemical alone that would be required to elicit the 85 
effect of the whole mixture. However, experimental data have often shown deviation 86 
from this rule (Cedergreen, 2014), indicating more than additive interaction (an effect 87 
higher than expected, based on CA) or less than additive interaction (an effect lower 88 
than expected, based on CA).  89 
To evaluate the CA deviations we prepared different binary and ternary mixtures 90 
containing SAs, with concentrations of each compound that, based on the CA concept, 91 
would be expected to result in a 50% immobilisation of D. magna after incubation for 92 
48h. The scope of this experiment was to provide only a preliminary assessment of the 93 
synergistic tendencies of the molecules studied to allow later selection of the most 94 
appropriate mixtures for further evaluation. Mixtures that showed a strong indication of 95 
interactions that were more than additive, were then tested using a range of reducing 96 
concentrations of the components, in an equi-toxicity concentration ratio design. These 97 
latter data were processed using CompuSyn software (Chou and Martin, 2005) to 98 
identify the EC50 of each mixture, and to evaluate, more precisely, the interactions of its 99 
components (antagonism/synergy) at all effect levels. For binary mixtures, synergy was 100 
also evaluated using the curvilinear isobologram method proposed by Tallarida (2006) 101 
for heterodynamic drugs. 102 
 103 
Materials and Methods 104 
 105 
Culture conditions 106 
 107 
Ephippia of D. magna were originally provided by ECOTOX (Milano, Italy). A single 108 
clone culture was selected based on the correct level of sensitivity to potassium 109 
dichromate (ISO, 1996) which was then rechecked periodically (every four months).  110 
The subject organisms were maintained in Aachener Daphnien Medium (ADaM: 111 
hardness 193 mg CaCO3L-1; Klüttgen et al., 1994a,b) at 20±1°C, with a photoperiod of 112 
16 h light (2.6 µE m-2 s-1): 8 h dark. Their health status was optimal, and they did not 113 
show any sign of stress: mortality rate was ≤ 2% per week; reproduction rate was around 114 
10 neonates per day per individual; ephippia and/or males never appeared in the culture. 115 
They were fed three times per week with Scenedesmus dimorphus (8 x 105 cells mL-1). 116 
The alga was cultured in 2L BBM (Bold Basal Medium) enriched with 3 g of sterilised 117 
poultry dung and suspended by bubbling filtered air. Before it was fed to the Daphnia 118 
culture, the chlorophyte was filtered through a 50 µm laboratory test sieve (Endecotts 119 
LTD, London, England), centrifuged at 3000 g for 10 min, resuspended in 25% BBM 120 
medium at a concentration of 2 x 108 cells mL-1 and stored at 4 ± 1 °C.  121 
 122 
Chemicals 123 
 124 
Analytical grade compounds were purchased from Sigma–Aldrich (Milano, Italy) and 125 
were of the following minimum purity: Sulfadiazine [68-35-9] (SDZ) 99%, 126 
Sulfaguanidine [57-67-0] (SGD) 99%, Sulfamerazine [127-79-7] (SMA) 99%, 127 
Sulfadimethoxine [122-11-2] (SDM) 98%, Sulfamethazine[57-68-1] (SMZ) 99%, 128 
Sulfaquinoxaline [59-40-5] (SQO) 95%. The majority of these compounds have good 129 
water solubility at a slight alkaline pH (O’Neil, 2006; Białk-Bielińska et al., 2012), 130 
therefore for these compounds the preparation of their solutions in ADaM at 131 
concentrations equal to their individual EC50 could be achieved by simple stirring at 132 
room temperature. In the cases of SQO and SDZ, complete solubilisation in ADaM was 133 
achieved by returning the pH of the medium to its original value (8.0) using 1 M NaOH 134 
(De Liguoro et al., 2009, 2010)  135 
 136 
Assayed mixtures 137 
 138 
Drug mixtures for the immobilisation test were prepared taking into account the EC50 of 139 
individual compounds. All the possible binary mixtures (15) of the 6 compounds were 140 
assayed. Ternary mixtures to be assayed were chosen on the basis of the results already 141 
obtained with binary mixtures. After preparing solutions of each single compound in 142 
ADaM medium, corresponding to its individual EC50; equal volumes of two or three of 143 
these solutions were mixed to generate the binary and ternary mixtures (Table 1). In this 144 
way, based on the principle of CA, a 50% immobilisation effect would have been 145 
expected from each mixture after 48h incubation. Therefore, any detected effect >50% 146 
would have been considered as an indication of more than additive interaction. 147 
Similarly, any detected effect <50% would have been considered as an indication of less 148 
than additive interaction. In other words, for any number of additive agents the following 149 
equation holds: 150 
 151 
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 153 
where dAi is the dose/concentration of Ai  in a mixture that produces a specified effect, 154 
and DAi is the dose/concentration of the single agent which on its own elicits the same 155 
effect as the mixture (Kortenkamp and Altenburger, 1998). 156 
Given that the CA principle is rooted in the assumption of the constant relative potency 157 
of the drugs being combined (Tallarida, 2006) and that with the six SAs studied (Figure 158 
1), this was not the case; as already indicated (see Introduction section), the preliminary 159 
tests were introduced in order to obtain an indication of which mixtures showed 160 
synergistic tendencies. Mixtures with a strong effect (> 90%) were then further assayed 161 
in a range of reducing concentrations (Table 2). This in order to plot their concentration-162 
response curves, derive the EC50s, and proceed to a reliable analysis of the interactions 163 
between their components, using CompuSyn software (Chou and Martin, 2005). The 164 
CompuSyn program integrates the different shapes of the curves in the calculation of 165 
the Combination Index for the evaluation of synergy; in this way, the constant relative 166 
potency of the combined drugs is not a prerequisite. For combinations of two drugs (not 167 
for three drugs), we also addressed the question using the equations proposed by 168 
Tallarida (2006) for heterodynamic drugs, which allow the isobole of additivity to be 169 
represented as a region bounded by two well-defined curves. 170 
 171 
Toxicity tests 172 
 173 
Acute toxicity tests were performed according to the Guideline 202 ‘Daphnia sp., Acute 174 
Immobilisation Test’ (OECD, 2004). The ADaM medium was used for Controls and the 175 
dilution of test compounds. Eight groups of 5 young daphnids (third brood neonates; 176 
<24 h) were exposed to each of the assayed mixtures (Table 1 and Table 2) or used as 177 
controls. The organisms were fed for about 1 h with 100% pure, dried Spirulina powder 178 
(15 mg in 100 mL ADaM) just before the start of the experiment, and then each group 179 
was incubated in a 20 mL glass vessel loosely covered with parafilm, and containing 10 180 
mL of the test solution, under the same conditions (light, temperature) used for culturing. 181 
Pre-feeding of the organisms is not deemed necessary by the test guideline, however in 182 
our experience is strongly advisable as it helps to sustain 100% survival in the control 183 
groups. The number of immobile daphnids recorded after 48h was the endpoint for effect 184 
calculation. 185 
 186 
Data Analysis  187 
 188 
Data were processed using CompuSyn software for Drug Combinations and General 189 
Dose-Effect Analysis (Chou and Martin, 2005). Raw data for the effects of both single 190 
drugs and mixtures were entered. CompuSyn fitted the data and provided the model 191 
parameters and the concentration-effect plots. The model parameters were the EC50 and 192 
the shape value “m” of the Hill curve f as a function of the chemical concentration x, as 193 
given by: 194 
 195 
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 197 
If the exponent m is greater than 1, the curve is sigmoidal, when it is equal to 1 the curve 198 
is hyperbolic (Chou and Martin, 2005). The most relevant aspect of CompuSyn is to 199 
provide the evaluation and the plots that report Combination Indices. The Combination 200 
Index (CI) quantifies the dose-effect relationship on the basis of “mass-action law” to 201 
evaluate the effect of combination of chemicals (Chou and Martin, 2010). The CI index 202 
furnishes a value that quantitatively indicates synergism (CI < 1), additive effect (CI = 203 
1), and antagonism (CI > 1). Here we used this tool to evaluate possible synergy among 204 
the different compounds.  205 
To further evaluate the possible synergy between pairs of chemicals, we completed an 206 
isobologram analysis at EC50. Since there is no obvious basis upon which to distinguish 207 
whether chemical A is contributing to chemical B or vice versa, the use of dose 208 
equivalence leads to not one but to two possible isoboles of additivity, depending on 209 
how the concept of dose equivalence is applied (Tallarida 2006). This means that rather 210 
than being a single straight line, the isobole becomes an area bordered by two curved 211 
lines. In particular, according to previous indications (Tallarida, 2006), when two 212 
compounds have two different shapes (or exponents) of the dose-effect curve, the 213 
signature of the synergy/antagonism of their mixture must be found outside the region 214 
bounded by two curves. In the EC50 isobologram estimation, the equivalent doses were 215 
computed using two equations that describe the upper and lower bounds of the additivity 216 
area and are expressed as: 217 
 218 
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 220 
where q and p are the exponents of the Hill curves (m in the previous equation) for the 221 
chemicals A and B, respectively (Tallarida, 2006). A50 and B50 refer to the EC50 of each 222 
of the two chemicals, while a and b are the doses (or concentrations) of each chemical 223 
A and B. When p = q, the dose equivalent for B collapses to a single straight line, as can 224 
be seen from the equation above. However, in the general case, the greater the difference 225 
between q and p, the farther from this diagonal the two isoboles are (Tallarida, 2006). 226 
Since we evaluated the Hill shape exponent with CompuSyn, and the program reports 227 
the associated error for the computed exponent, we highlighted in the isobologram the 228 
uncertainty of the computed exponents. Thus, in the isobologram we also included the 229 
“worst-case isobole”, in which the larger exponent is increased by summing its error, 230 
and the smaller exponent is decreased by subtracting its error. In practice, if q>p and εq 231 
and εp are the corresponding estimated errors, the worst-case isobole is computed with 232 
the highest possible ratio r=(q + εq)/(p - εp). In this way, if the measured point of the 233 
combination dose exceeds this “fatter” isobole the indication of synergy (or antagonism) 234 
gains greater confidence. 235 
 236 
 237 
Results 238 
 239 
Raw data for acute toxicity of single compounds were already available from previous 240 
experiments run in our lab (Dalla Bona et al., 2014) under the same conditions (T, light 241 
cycle, length of exposure, age of daphnids, feeding) used for mixture assays. The relative 242 
concentration-response curves and EC50s, generated using CompuSyn software, are 243 
presented in Figure 1. 244 
In all tests, validity criteria were fulfilled as control survival (mobility) was 100%, and 245 
the recorded values of water quality parameters, measured at the beginning and at the 246 
end of the test, were always within the following ranges: pH 7.9–8.1, dissolved oxygen 247 
7.70–8.40 mg L-1. Temperature stability (20±1°C) of the medium was guaranteed by the 248 
use of a refrigerated incubator. Six binary mixtures of the 15 assayed, gave indications 249 
of more than additive interaction (Figure 2). The following had more than 90% effect: 250 
SMA+SDZ (97.5%); SQO+SDM (92.5%); SGD+SDZ (92.5%); SDM+SGD (100%). 251 
These were re-assayed in a range of reducing concentrations (from 0.5 to 0.25 EC50 of 252 
each component) under the same conditions used in the previous tests: their 253 
concentration-effect curves and EC50s are shown in Figure 3 and compared to the effect 254 
curves predicted by CA. In general, their effects were confirmed to be synergic (Figure 255 
4); at high effect levels - in three cases out of four, the synergy was strong (Combination 256 
Index < 0.3; Chou and Martin, 2005). At the 50% effect level, synergy was also 257 
confirmed by applying the equations proposed by Tallarida (2006); however, with 258 
SGD+SDM and SMA+SDZ the EC50 fell just below the confidence limit of the 259 
additivity area (Figure 5). 260 
Three ternary mixtures were tested, and all gave indications of greater than additive 261 
interaction (Figure 2). The following had greater than 90% effect: SDM+SGD+SDZ 262 
(100%); SMA+SGD+SDZ (100%). These were re-assayed in a range of reducing 263 
concentrations (from 0.33 to 0.165 EC50 of each component): their concentration-effect 264 
curves and EC50s are shown in Figure 3 and compared to the effect curves predicted by 265 
CA. Their effects were confirmed to be synergic at all effect levels (Figure 4).  266 
Predicted No-Effect Concentrations (PNECs), for individual compounds in mixtures, 267 
obtained by applying an Assessment Factor of 1000 to the EC50s (CVMP/VICH/790/03), 268 
were always > 40 µg L-1, with the exception of SGD (> 1 µg L-1).  269 
 270 
Discussion 271 
 272 
Following an in-depth study on the hydrolysis of SAs in aqueous solutions, Białk-273 
Bielińska et al. (2012) concluded that under typical environmental conditions (pH and 274 
temperature) SAs are hydrolytically stable with a long half-life, and that all could be 275 
assumed to be hydrolytically stable at pH 9 and 25°C for least 1 year. Moreover, in 276 
previous experiments with D. magna (De Liguoro et al., 2009, 2010) it was verified, 277 
using HPLC analysis, that the 48 h level of decline of the above mentioned compounds 278 
under the conditions used in the tests (pH 8.0; 20°C) was between 0 and 13%. Based on 279 
the CRED (Moermond et al., 2016), in acute toxicity tests with stable substances, 280 
nominal concentrations without further measurements are acceptable. Furthermore, 281 
Guideline 202 ‘Daphnia sp., Acute Immobilisation Test’ (OECD, 2004) states that if the 282 
concentration of the test substance has been maintained throughout the test within ± 20 283 
per cent of the nominal initial concentration, the results can be based on the nominal 284 
values. Thus, in the present study, the use of HPLC analysis was rendered redundant and 285 
consequent undesirable excess use of solvents was avoided, with test results being based 286 
on nominal concentrations.  287 
The various SAs evaluated in this study share the same mechanism of action and cellular 288 
target (Eguchi et al., 2004); consequently, their combinations should follow the CA 289 
principle (Cedergreen, 2014). The 15 (preliminary) binary tests, where all possible pairs 290 
were tested, showed 9 cases of less than additive interaction (Combination Index >1), 291 
and 6 cases of more than additive interaction (Combination Index <1). The 3 292 
(preliminary) ternary tests, chosen, based on binary test results, all showed more than 293 
additive interaction. In some cases the deviation from the rule of CA, in one way or 294 
another, was strong (Figure 2). The CA principle, however, is rooted in the assumption 295 
of a constant relative potency of the drugs being combined. In other words, the Hill 296 
coefficients (Faust et al., 2003), which  respectively describe their concentration-effect 297 
relations, should be equal (Tallarida, 2006). With the studied SAs this assumption did 298 
not hold true (Figure 1). Therefore, the positive results of the preliminary tests were 299 
taken only as a possible indication of synergy, rather than definitive proof.  The more 300 
promising mixtures were then re-assayed in a range of five concentrations, spreading 301 
experimental data points below and above the EC50 value, as suggested by Chou for the 302 
use of the CompuSyn application (Chou and Martin, 2005). At the 50% effect level, 303 
synergy was confirmed for all four binary mixtures by applying the equations of 304 
Tallarida. To further check the synergetic effects, worst-case isoboles were also included 305 
by adding the computed error to the larger exponent and subtracting the computed error 306 
from the lowest exponent. Figure 5 shows that all the binary mixtures, passed this more 307 
restrictive test, indicating significant synergy around the EC50 combined dose.   308 
For a more comprehensive evaluation of the drug interactions, we used the CompuSyn 309 
program, which allows the evaluation of synergy at all effect levels, both for binary and 310 
ternary mixtures. Detected synergies (Figure 4) indicate that the concept of CA is not 311 
always precautionary as a reference model for the evaluation of the aquatic toxicity of 312 
SA mixtures. Interestingly, SDZ that is the only SA licensed for aquaculture in EU, and 313 
therefore more prone than other compounds to the contamination of the aquatic 314 
environment, was frequently involved in synergic interactions. It should be noted, 315 
however, that synergies were generally stronger when immobilisation percentages were 316 
very high (Figure 4), i.e. when relatively high concentrations of SAs were mixed. This 317 
means that at the very low concentrations usually encountered in the natural 318 
environment, SA synergies may be of more limited relevance to D. magna. More 319 
generally, calculated PNECs for single components of each mixture indicate that the 320 
currently reported level of SA contamination (<1 µg L-1) should have no impact on the 321 
freshwater environment. Nevertheless, it would be of interest to assess the effects of the 322 
selected SA mixtures in the chronic D. magna Reproduction Test, which is indeed far 323 
more sensitive than the acute immobilisation test and allows the estimation of NOEC 324 
for PNEC calculation.  325 
The authors think that some experiments with similar SAs mixtures, on more sensitive 326 
species, such as cyanobacteria, would complement the present work. Indeed, 327 
cyanobacteria are generally considered to be the most sensitive aquatic organism to 328 
antibacterials; however, it has also been shown that green algae are more sensitive than 329 
daphnids to the toxicity of some selected SAs, with NOEC values in the range 0.02-1 330 
mg L-1 (Eguchi et al., 2004; De Liguoro et al., 2010). In the natural environment, some 331 
cascade effect on daphnids may also be expected, as green algae are their basic food 332 
resource. Such an effect could not be highlighted by the acute immobilisation test where, 333 
in order to avoid any nutritional variation among the experiments, daphnids were fed 334 
only with a calibrated quantity of dried spirulina. Possible synergic interactions with 335 
Trimethoprim (TMP) or Pyrimethamine (PMT), two SA potentiators frequently 336 
included in VMPs, should be taken into consideration in addition. For instance, Eguchi 337 
et al. (2004) showed that pairing SMZ, SDZ and SDM with TMP or PMT strongly 338 
enhanced their algal growth inhibition effects. Overall, the indications of synergy 339 
between SAs observed during these tests open the way for a range of new experiments 340 
to further deepen our understanding of this phenomenon. 341 
 342 
Conclusions 343 
 344 
A range of methods is available for the evaluation of the synergistic interactions of drug 345 
mixtures. As suggested by Foucquier and Guedj (2015), in the absence of a reference 346 
methodology appropriate for all situations, the evaluation of the impacts of various drug 347 
combinations may be facilitated by the collective use of different approaches. Here, 348 
binary mixtures of veterinary SAs were evaluated using two different models, and both 349 
generally confirmed the possibility of synergistic interactions among these compounds. 350 
Whilst their combined acute toxicity to D. magna still seems too low to represent a real 351 
threat in the natural environment, future studies with SAs mixtures should focus on the 352 
possible chronic harm to daphnids and to other, more sensitive, aquatic organisms. 353 
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Figure Captions 447 
 448 
Figure 1. Concentration-effect curves of single SAs in D. magna immobilisation test (48h). r=correlation 449 
coefficient; m=exponent of the Hill-curve that defines the curve slope. Vertical error bars show standard 450 
deviation (4 vessels, each with 5 daphnids). SDM, sufadimethoxine; SGD, sulfaguanidine; SDZ, sulfadiazine; 451 
SMA, sulfamerazine; SQO, sulfaquinoxaline; SMZ, sulfamethazine. 452 
Figure 2. Effect percentage of binary and ternary mixtures of SAs in D. magna immobilisation test (48h); 453 
based on the CA principle a 50% effect was to be expected. However, deviations from this rule may also be 454 
the consequence of the inconstant relative potency of the drugs being combined (Tallarida, 2006) Horizontal 455 
error bars show standard deviation (8 vessels, each with 5 daphnids). SMA, sulfamerazine; SGD, 456 
sulfaguanidine; SDZ, sulfadiazine; SDM, sulfadimethoxine; SQO, sulfaquinoxaline; SMZ, sulfamethazine. 457 
Figure 3. Concentration-effect curves of binary (a,b,c,d) and ternary (e,f) mixtures of SAs in D. magna 458 
immobilisation test (48h). Vertical error bars show standard deviation (8 vessels, each with 5 daphnids). 459 
Dashed lines are the concentration-effect curves predicted by Concentration Addition principle. SDM, 460 
sufadimethoxine; SGD, sulfaguanidine; SDZ, sulfadiazine; SMA, sulfamerazine; SQO, sulfaquinoxaline.  461 
Figure 4. Graphic representations obtained from the CompuSyn Report for SAs binary (a,b,c,d) and ternary 462 
mixtures (e,f) assayed on D. magna: Combination Index <1 indicates synergic interaction. SDM, 463 
sufadimethoxine; SGD, sulfaguanidine; SDZ, sulfadiazine; SMA, sulfamerazine; SQO, sulfaquinoxaline. 464 
Figure 5. Isobolograms of SAs binary mixtures assayed on D. magna.  For compounds with a variable potency 465 
ratio, synergy is detected only if the EC50 of the mixture lies below the region of the plane bounded by the 466 
two curves of additivity for a 50% effect (Tallarida, 2006). Dotted lines represent curves of additivity. Dashed 467 
lines are their confidence limits based on Hill coefficient variability. SGD, sulfaguanidine; SDM, 468 
sufadimethoxine; SDZ, sulfadiazine; SMA, sulfamerazine; SQO, sulfaquinoxaline. 469 
Table 1. Preliminary assays of binary (B) and ternary (T) mixtures of SAs in D. magna immobilisation test.  
Mixture Sulfadimethoxine 
(mg/L) 
Sulfaguanidine 
(mg/L) 
Sulfadiazine 
(mg/L) 
Sulfaquinoxaline 
(mg/L) 
Sulfamethazine 
(mg/L) 
Sulfamerazine 
(mg/L) 
 
B1 132.8 3     
B2 132.8  95.4    
B3 132.8   69   
B4 132.8    104.4  
B5 132.8     102.5 
B6  3 95.4    
B7  3  69   
B8  3   104.4  
B9  3    102.5 
B10   95.4 69   
B11   95.4  104.4  
B12   95.4   102.5 
B13    69 104.4  
B14    69  102.5 
B15     104.4 102.5 
T1 88.5 2 63.6    
T2 88.5 2  46   
T3  2 63.6   68.3 
 Table 2. Assays in a range of reducing concentrations of selected binary and ternary mixtures of SAs in D. 
magna immobilisation test. 
 
Combination 
 
SAs 
 
 
Assayed concentrations (mg/L) 
     
Binary Sulfadimethoxine 132.8 116.2 99.6 83.0 66.4 
 Sulfaguanidine 3.0 2.6 2.3 1.9 1.5 
Binary Sulfamerazine 102.5 89.7 76.9 64.1 51.3 
 Sulfadiazine 95.4 83.5 71.6 59.6 47.7 
Binary Sulfaguanidine 3.0 2.6 2.3 1.9 1.5 
 Sulfadiazine 95.4 83.5 71.6 59.6 47.7 
Binary Sulfaquinoxaline 69.0 60.4 51.8 43.1 34.5 
 Sulfadimethoxine 132.8 116.2 99.6 83.0 66.4 
Ternary Sulfadimethoxine 88.5 77.5 66.4 55.4 44.3 
 Sulfaguanidine 2.0 1.8 1.5 1.3 1.0 
 Sulfadiazine 63.6 55.7 47.7 39.8 31.8 
Ternary Sulfaguanidine 2.0 1.8 1.5 1.3 1.0 
 Sulfadiazine 63.6 55.7 47.7 39.8 31.8 
 Sulfamerazine 68.3 59.8 51.2 42.7 34.2 
 





